Trading Signals: VRTX Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Vertex Pharmaceuticals Inc)
| VRTX latest price $128.2600 (2.38%) ($124.2700 - $128.3600) on Tue. Nov. 17, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.36% (three month average) | | RSI | 61 | | Latest Price | $128.2600(2.38%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | VRTX advances 1.6% a day on average for past five trading days. | | Weekly Trend | VRTX declines -1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | | Correlated ETFs | Broad market will support VRTX advance at 0% a week (0% probability)
IBB(63%) XLV(58%) XBI(55%) VUG(46%) IVW(45%) | | Factors Impacting VRTX price | VRTX will decline at least -1.68% in a week (0% probabilities).
VIXM(-20%) TLT(-12%) UUP(-7%) IGOV(-3%) TIP(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.68% (StdDev 3.36%) | | Hourly BBV | 0 () | | Intraday Trend | 2.5% | | | | | |
|
| 5 Day Moving Average | $122.42(4.77%) | | 10 Day Moving Average | $121.54(5.53%) | | 20 Day Moving Average | $120.69(6.27%) | | To recent high | -9.3% | | To recent low | 30.2% | | Market Cap | $33.364b | | | | | | |
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. |